Santé

Recently, Tennessee’s GOP-controlled Statehouse approved legislation that penalizes adults who assist minors in receiving gender-affirming care without parental consent. This move is part of a wave of anti-LGBTQ+ laws that have been passed in Tennessee over the years, making it the state with the most anti-LGBTQ+ laws since 2015. The bill, which mirrors language from
0 Comments
A novel strategy utilizing sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) has shown promising results for patients with relapsed or refractory hematologic cancers. The approach, proposed by researchers from Zhejiang University School of Medicine in China, involves administering CD7 CAR T-cell therapy to achieve complete remission, followed
0 Comments
Restricting access to embargoed journal articles has sparked controversy in the medical news publications sphere, with some experts likening it to a “don’t ask, don’t tell” policy. This move by the New England Journal of Medicine has left many questioning the implications for the dissemination of crucial medical information. The debate over testing testosterone levels
0 Comments
In a recent phase IIb PARADIGM trial, a novel treatment candidate for amyotrophic lateral sclerosis (ALS) called PrimeC has shown promising results. This formulation, which combines two FDA-approved drugs, ciprofloxacin and celecoxib, met its primary safety and secondary endpoints. The study results were presented by Merit Cudkowicz, MD, MSc, at the American Academy of Neurology
0 Comments
Antipsychotic medications have long been a controversial subject when it comes to treating dementia patients. A recent population-based matched cohort study from the U.K. shed light on the significant risks associated with the use of antipsychotics in dementia patients. The study revealed that individuals prescribed antipsychotics were at a substantially higher risk of suffering from
0 Comments